Skip to main content

Table 1 Patient demographics and perioperative data

From: Enumeration of circulating endothelial cell frequency as a diagnostic marker in aortic valve surgery - a flow cytometric approach

  CAVR (n = 11) TAVI (n = 11) p-value
Age [yrs] 69.0 ± 11.2 81.0 ± 4.8 0.004
Female [N] 5 (45.5%) 7 (63.6%) 0.670
Height [cm] 175.6 ± 5.0 166.2 ± 9.2 0.011
Weight [kg] 84.9 ± 11.6 65.5 ± 12.4 0.002
Log. euroSCORE 5.33 ± 4.40 19.37 ± 7.05 <0.001
STS score 1.90 ± 1.06 7.85 ± 3.59 <0.001
CAD [N] 4 (36.4%) 8 (72.7%) 0.198
Pre-operative creatinine [mg/dL] 0.92 ± 0.2 1.52 ± 0.9 0.042
Pre-operative hemoglobin [g/dL] 13.8 ± 1.3 11.6 ± 0.9 0.001
Pre-operative CK [U/L] 63.8 ± 24.7 42.0 ± 27.1 0.053
Pre-operative CK-MB [U/L] 6.73 ± 1.6 10.36 ± 5.6 0.053
Pre-operative Troponin T [μg/L] 0.01 ± 0.01 0.08 ± 0.10 0.031
Pre-operative EF [%] 61.9 ± 23.1 49.9 ± 26.0 0.355
Pre-operative AVA [cm2] 0.62 ± 0.30 0.60 ± 0.22 0.922
Pre-operative cardiac decompensation [N] 0 4 (36.4%) 0.045
Arterial hypertension [N] 10 (90.9%) 11 (100.0%) 1.000
Hyperlipoproteinemia [N] 10 (90.9%) 11 (100.0%) 1.000
Pre-operative pulmonary hypertension [N] 0 2 (18.2%) 0.476
Previous statin therapy [N] 10 (90.9%) 11 (100.0%) 1.000
History of AMI [N] 0 1 (9.1%) 0.168
  1. AVA aortic valve area, CAD coronary artery disease, CK creatine kinase, CK-MB creatine kinase-muscle/brain (cardiac specific isoform), EF ejection fraction, AMI acute myocardial infarction
  2. Statistically significant p-values are presented in bold